SEC Filings

SEC Filings

Filing date Description Form Filing Group Issuer View
View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
Eidos Therapeutics, Inc.
View HTML

Amendment to a previously filed 4

4/A
3,4,5
Eidos Therapeutics, Inc.
View HTML

Amendment to a previously filed 4

4/A
3,4,5
Eidos Therapeutics, Inc.
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Eidos Therapeutics, Inc.
View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
Eidos Therapeutics, Inc.
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Eidos Therapeutics, Inc.
View HTML

An amendment to a SC 13D filing

SC 13D/A
3,4,5
Eidos Therapeutics, Inc.
View HTML

Initial filing by director officer or owner of more than ten percent.

3
3,4,5
Eidos Therapeutics, Inc.
View HTML

Statement of changes in beneficial ownership of securities

4
3,4,5
Eidos Therapeutics, Inc.
View HTML

Report of unscheduled material events or corporate event

8-K
Current Reports
Eidos Therapeutics, Inc.

Copyright Morningstar